🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for malignant pancreatic neoplasm

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors NCT06821048Phase 11 site📍 Hangzhou Weijia Fang, MD · Tests: Intraperitoneal infusion of FAST CEA-targeted CAR-T Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals NCT06122896EARLY Phase 12 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Screening Blood Tests, Endoscopic Ultrasound, Magnetic Resonance Imaging, Magnetic Resonance Cholangiopancreatography A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites📍 Hangzhou📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: CEA-targeted CAR-T cells MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer NCT07045571n/a1 site📍 Shanghai Yingbin Liu, MD, PhD, FACS DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib Pancreas Registry and High Risk Registry NCT02775461n/a2 sites📍 New York📍 New York Icahn School of Medicine at Mount Sinai A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations NCT06835569Phase 114 sites📍 Orlando📍 Tampa📍 Boston Alterome Therapeutics, Inc. · Tests: ALTA3263, cetuximab, mFOLFOX6, Pembrolizumab, Pemetrexed + Cisplatin /Carboplatin Delayed Gastric Emptying After Pancreatic Surgery NCT07382791n/a1 site📍 Taipei National Taiwan University Hospital · Tests: pancreatectomy Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas NCT06914674Phase 21 site📍 Shanghai Fudan University · Tests: Tamoxifen 20 mg A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies NCT04678648Phase 13 sites📍 Los Angeles📍 Denver📍 Nashville RasCal Therapeutics, Inc. · Tests: RSC-1255 Dose Escalation, RSC-1255 Dose Expansion Distance-Based Exercise to Preserve Function and Prevent Disability NCT07059884NA23 sites📍 Dublin📍 Fremont📍 Fresno Alliance for Clinical Trials in Oncology · Tests: Exercise intervention, Telemedicine, Aerobic Exercise Intervention, Exercise Intervention, Accelerometry RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT NCT01885299n/a13 sites📍 Colorado Springs📍 Miami📍 Brunswick The Radiosurgery Society · Tests: SRS/SBRT Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion NCT05245500Phase 125 sites📍 Phoenix📍 Lone Tree📍 Jacksonville Bristol-Myers Squibb · Tests: MRTX1719 Registry of Subjects at Risk of Pancreatic Cancer NCT04095195n/a4 sites📍 Rozzano📍 Peschiera del Garda📍 Milan Associazione Italiana per lo Studio del Pancreas · Tests: MRCP, Endoultrasonography A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies NCT04503265Phase 1, Phase 24 sites📍 Los Angeles📍 Baltimore📍 Nashville AtlasMedx, Incorporated · Tests: AMXI-5001:Dose Escalation Phase I, AMXI-5001:Dose Expansion Phase II CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors NCT07179692Phase 11 site📍 Hefei Chongqing Precision Biotech Co., Ltd · Tests: CEA-targeted CAR-T cells, CEA-targeted CAR-T cells, CEA-targeted CAR-T cells INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) NCT07403630NA2 sites📍 Palermo📍 Perugia Azienda Ospedaliero-Universitaria di Parma · Tests: Functional tests, Multi-omics analyses, Cytogenetics/ FISH Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) NCT06277531n/a2 sites📍 Beijing📍 Beijing Peking University Third Hospital Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites📍 Duarte📍 Los Angeles📍 Stanford Anusha Kalbasi · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma NCT01950572n/a1 site📍 Bethesda National Cancer Institute (NCI) Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study NCT06534762Phase 21 site📍 Hangzhou Zhejiang Provincial People's Hospital · Tests: Mirabegron Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors NCT05687123Phase 110 sites📍 Duarte📍 Irvine📍 Orange National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate, Magnetic Resonance Imaging, Positron Emission To… CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors NCT06937567EARLY Phase 11 site📍 Hangzhou Zhejiang University · Tests: CDH17 CAR-T, FAST LACO-Stim CDH17 CAR-T Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3) NCT06939023NA1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Laparoscopic minimally invasive left-sided pancreatecomy, Robot-assisted minimally invasive left-sided pancreatecomy Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features NCT05334836NA1 site📍 Shatin Chinese University of Hong Kong · Tests: MRI for pancreatic fat and liver fat quantitation Intravital Microscopy in Human Solid Tumors NCT03823144NA1 site📍 Jacksonville Mayo Clinic · Tests: Diagnostic Microscopy, Fluorescein Sodium Injection A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression NCT06051695Phase 1, Phase 212 sites📍 Gilbert📍 La Jolla📍 Los Angeles A2 Biotherapeutics Inc. · Tests: A2B694, A2B543, xT CDx with HLA-LOH Assay Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors NCT07301814n/a1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: Specific PET imaging agents targeting CLDN18.2 Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy? NCT05720338Phase 31 site📍 Cleveland Case Comprehensive Cancer Center · Tests: 19 French Blake Drain
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy